Yes and remember the sec had an issue before with
Post# of 148338
Quote:
CytoDyn included in its public filings the same, nearly boilerplate, disclosure of material weaknesses for nine consecutive years.
Quote:
CytoDyn included in its public filings the same, nearly boilerplate, disclosure of material weaknesses for nine consecutive years.